A human anti-(rhesus D) antibody (IgGlA) Fab fragment was cloned from an Epstein-Barr-virus-transformed cell line and expressed in Escherichia coli with the use of bacteriophage A vectors. The cloned protein is active in binding to human erythrocytes and permits the development of a recombinant reagent for the prevention of haemolytic disease of the newborn. The method offers a rapid and effective means of rescuing human Fabs from potentially unstable cell lines secreting human antibodies.
INTRODUCTION
A novel bacteriophage A vector system has previously been described for the expression, in Escherichia coli, of a combinatorial library of the mouse antibody repertoire [1] . The system was used to clone monoclonal Fab fragments of defined specificity from the repertoire with the use of RNA from a hyperimmunized spleen. It is, though, the cloning of the human immune repertoire that will ultimately yield the most therapeutically useful immunoglobulins. At present there are available a number of human hybridomas and Epstein-Barr-virus (EBV)-transformed cell lines, most notably producing antibodies against rhesus-blood-group antigens [2] [3] [4] [5] [6] and human-immunodeficiency-virus (HIV) proteins [7] . Such cell lines can, however, be unstable and cease secreting antibody [8] . They may also be of an unsuitable isotype, e.g. Epstein-Barr-virus-transformed cells often secrete IgM [9] , which does not trigger many cytotoxic mechanisms.
In this paper we describe the application of the combinatorial bacteriophage A system to extract from an Epstein-Barr-virustransformed cell line and introduce into a bacterial expression system a human anti-(rhesus D) (anti-RhD) Fab fragment. The Fab can now be linked to the desired effector function in a eukaryotic vector for stable expression in existing non-human mammalian cell lines, thus by-passing fears, associated with human cell lines, of human viral and DNA contamination of the secreted antibody.
MATERIALS AND METHODS

Design of primers
The heavy-chain 5' primers, VHla and VH3a, for y-chain amplification are designed to maximize sequence identity with the VH1 and VH3 subgroup families respectively (all sequences taken from ref. [10] and GenBank), although considerable crosspriming is expected. The 3' primer for the y-chain, CGlz, corresponds to part of the hinge region. A 5' control primer, CONGa, corresponds to the 5'-end of the CH1 domain. The 5' primers for amplification of the A-chain are designed to maximize sequence identity with known A-chain sequences (GenBank) and are termed VL1 to VL6. CL2 is a 3' primer corresponding to the 3'-end of known A-chains. The 5' control primer CONL1 corresponds to the 5'-end of known CAl sequences.
Library construction
Total RNA was isolated [11] (Promega) and 60 pmol of the appropriate 3' primer ( Table 1 ). The reaction mixtures were then subjected to 35 rounds of amplification (Perkin-Elmer Cetus thermal cycler) at 52°C for 2 min, 72°C for 1.5 min and 91°C for 2 min, followed by a final incubation at 72°C for 10 min. A sample of the reaction material was subjected to electrophoresis on a 2 % agarose gel. After successful amplification (denoted by a band of approx. 650 bp) the remainder of the RNA -cDNA was amplified, and the products of a common 3' primer were pooled, extracted with phenol/chloroform and precipitated with ethanol. The DNA was then digested with the appropriate restriction enzymes, extracted and precipitated again before being subjected to electrophoresis on a 2 % agarose gel. The desired band was purified by using Geneclean (Biol0l, La Jolla, CA, U.S.A.), and DNA was ligated into the phosphatase-treated vector arms AHC1 or ALCI [1] in roughly equimolar amounts before packaging with Gigapack Gold Plus II (Stratagene, La Jolla, CA, U.S.A.). The resulting libraries were titred and assayed for the expression of heavy chain (anti-decapeptide [1] ) or light chain (anti-A-chain; Southern Biotech, Birmingham, AL, U.S.A.). These libraries were amplified and bacteriophage DNA was purified by a glycerol-step-gradient method. Approx. 10 ,ug of this DNA was digested with the appropriate restriction enzymes, treated with phosphatase, digested with EcoRI, re-ligated and packaged as described previously [1] . The Table 1 . Primers used for amplification of human yl-chain (Fd) and A-chain sequences VHla and VH3a are 5' primers for the amplification of the y-chain. The XhoI site for cloning into the heavy-chain vector AHC2 is shown underlined. CGlz is the 3' primer for the y-chain. The SpeI site for cloning into AHC2 is underlined. CONGa is a 5' control primer. VL1 to VL6 are 5' primers for amplification of A-chain sequences. The Sacl site for cloning into the ALCI is underlined. CL2 is a 3' primer for the A-chains; the XbaI site is underlined. CONLI is a 5' control primer. library was examined for co-expression of heavy chains and light chains before amplification and storage at 4°C in 0.3 % chloroform.
Antigen-binding properties of the cloned protein
The ability of the cloned Fab to bind to RhD( +) and RhD(-) erythrocytes was examined by flow cytometry. A number of plaques found to co-express both the light chains and the heavy chains were cored, and the plasmids were excised, with the aid of the helper bacteriophage R408 (Stratagene), and infected into XL1 Blue (Strategene). Cultures of the infected cells were induced overnight at room temperature with 5 (Fig. 2) .
RESULTS
Library construction
Heavy-chain and light-chain sequences were amplified using the primers listed in Table 1 . Yields given by the various primer pairings were examined by agarose-gel electrophoresis. Successful amplification was denoted by a single band at 650 bp (Fig. 1) . Several amplifications were performed with the effective primers, and the individual products were pooled and digested with the appropriate restriction enzymes, before ligation into the vector arms. This gave a yl-chain library of 2 x 106 members and a Achain library of 4 x 106 members. Bacteriophage DNA prepared from these libraries was digested with the appropriate enzymes [1] and ligated together, creating a combinatorial library of 105 members, 88 % of which expressed both yl-chains and A-chains.
Antigen-binding properties of the cloned protein
The 18 bacteriophages co-expressing both chains were plaquepurified, and plasmids were excised (by co-infection with helper bacteriophage) and used to transform E. coli. Protein expression was induced, and five cell supernatants were affinity-purified and examined by SDS/PAGE (results not shown). Under nonreducing conditions a single band at 50 kDa was observed, and this yielded a doublet at 25 kDa under reducing conditions. The isolated Fabs were incubated with both RhD(+) and RhD(-) erythrocytes and analysed by flow cytometry. All five clones were shown to be positive; an example is illustrated in Fig. 2 . The greatest potential of human repertoire cloning is in the generation of monoclonal antibodies with desired specificity. At present, though, the technology is limited by the screening methods employed, which are restricting in both the type of antigen that can be screened for and the numbers that can be processed. Here we show it is possible to take advantage of existing human cell lines to extract Fab for expression in bacteria, thus readily permitting manipulations such as the addition of new constant regions for stable expression in non-human cell lines and random mutagenesis to increase affinity.
The bacteriophage system permits analysis of correct expression of light chains and heavy chains at an early stage in cloning. Where there is a fusion partner, the presence of nonproductive antibody genes at the mRNA level will lead to the amplification of sequences encoding non-functional proteins. In mouse hybridomas there has been a frequency of positives as low as 1 in 1000 (L. Sastry, personal communication). By screening at the bacteriophage level, which is possible with the combinatorial approach, low-frequency positives can be identified.
